Ali Behbahani - Net Worth and Insider Trading

Over the past 18 months, Ali Behbahani made no insider transaction in Metacrine Inc (MTCR). Other recent insider transactions involving Metacrine Inc (MTCR) include a net purchase of 435,875 shares made by Braden Michael Leonard , a net sale of 380,605 shares made by Preston Klassen , and a net sale of 107,054 shares made by Michael York .

In summary, during the past 3 months, insiders sold 0 shares of Metacrine Inc (MTCR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 487,659 shares of Metacrine Inc (MTCR) were sold and 435,875 shares were bought by its insiders, resulting in a net sale of 51,784 shares.

Metacrine Inc (MTCR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Ali Behbahani made no insider transaction in CRISPR Therapeutics AG (CRSP). Other recent insider transactions involving CRISPR Therapeutics AG (CRSP) include a net sale of 325,337 shares made by Samarth Kulkarni , a net sale of 5,860 shares made by James R. Kasinger , and a net sale of 3,524 shares made by Raju Prasad .

In summary, during the past 3 months, insiders sold 89,721 shares of CRISPR Therapeutics AG (CRSP) in total and bought 0 shares, with a net sale of 89,721 shares. During the past 18 months, 334,721 shares of CRISPR Therapeutics AG (CRSP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 334,721 shares.

CRISPR Therapeutics AG (CRSP)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Genocea Biosciences Inc (GNCAQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Genocea Biosciences Inc (GNCAQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Genocea Biosciences Inc (GNCAQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Ali Behbahani made no insider transaction in Nkarta Inc (NKTX). Other recent insider transactions involving Nkarta Inc (NKTX) include a net sale of 10,257 shares made by James Trager , a net sale of 5,497 shares made by David Shook , and a net sale of 15,092 shares made by Paul J Hastings .

In summary, during the past 3 months, insiders sold 4,143 shares of Nkarta Inc (NKTX) in total and bought 5,000,000 shares, with a net purchase of 4,995,857 shares. During the past 18 months, 42,076 shares of Nkarta Inc (NKTX) were sold and 5,000,000 shares were bought by its insiders, resulting in a net purchase of 4,957,924 shares.

Nkarta Inc (NKTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Ali Behbahani made no insider transaction in Adaptimmune Therapeutics PLC (ADAP). Other recent insider transactions involving Adaptimmune Therapeutics PLC (ADAP) include a net sale of 115,184 shares made by Adrian Rawcliffe , a net sale of 48,376 shares made by John Lunger , and a net sale of 46,074 shares made by Bertrand William C Jr .

In summary, during the past 3 months, insiders sold 0 shares of Adaptimmune Therapeutics PLC (ADAP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 315,048 shares of Adaptimmune Therapeutics PLC (ADAP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 315,048 shares.

Adaptimmune Therapeutics PLC (ADAP)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Ali Behbahani made no insider transaction in Akouos Inc (AKUS). Other recent insider transactions involving Akouos Inc (AKUS) include a net purchase of 29,992,668 shares made by Kearny Acquisition Corp ,

In summary, during the past 3 months, insiders sold 0 shares of Akouos Inc (AKUS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Akouos Inc (AKUS) were sold and 29,992,668 shares were bought by its insiders, resulting in a net purchase of 29,992,668 shares.

Akouos Inc (AKUS)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Oyster Point Pharma Inc (OYST) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Oyster Point Pharma Inc (OYST) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Oyster Point Pharma Inc (OYST)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Ali Behbahani made no insider transaction in Trevi Therapeutics Inc (TRVI). Other recent insider transactions involving Trevi Therapeutics Inc (TRVI) include a net sale of 14,243 shares made by Lisa Delfini ,

In summary, during the past 3 months, insiders sold 0 shares of Trevi Therapeutics Inc (TRVI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 14,243 shares of Trevi Therapeutics Inc (TRVI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 14,243 shares.

Trevi Therapeutics Inc (TRVI)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Ali Behbahani made 1 insider transaction in Black Diamond Therapeutics Inc (BDTX) with a net purchase of 1,000,000. Other recent insider transactions involving Black Diamond Therapeutics Inc (BDTX) include a net purchase of 3,140,000 shares made by Biotech Growth N V , a net purchase of 935,850 shares made by Ra Capital Healthcare Fund Lp , and a net purchase of 56,363 shares made by Fang Ni .

In summary, during the past 3 months, insiders sold 0 shares of Black Diamond Therapeutics Inc (BDTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 25,000 shares of Black Diamond Therapeutics Inc (BDTX) were sold and 5,132,213 shares were bought by its insiders, resulting in a net purchase of 5,107,213 shares.

Black Diamond Therapeutics Inc (BDTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Ali Behbahani made no insider transaction in Regulus Therapeutics Inc (RGLS). Other recent insider transactions involving Regulus Therapeutics Inc (RGLS) include a net sale of 14,580 shares made by Joseph P Hagan , a net sale of 5,468 shares made by Christopher Ray Aker , and a net sale of 5,468 shares made by Crispina Calsada .

In summary, during the past 3 months, insiders sold 0 shares of Regulus Therapeutics Inc (RGLS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 25,516 shares of Regulus Therapeutics Inc (RGLS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 25,516 shares.

Regulus Therapeutics Inc (RGLS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Ali Behbahani made no insider transaction in Mirum Pharmaceuticals Inc (MIRM). Other recent insider transactions involving Mirum Pharmaceuticals Inc (MIRM) include a net sale of 10,305 shares made by Peter Radovich , a net sale of 8,137 shares made by Jolanda Howe , and a net purchase of 161,963 shares made by Patrick J Heron .

In summary, during the past 3 months, insiders sold 4,303 shares of Mirum Pharmaceuticals Inc (MIRM) in total and bought 4,000 shares, with a net sale of 303 shares. During the past 18 months, 393,444 shares of Mirum Pharmaceuticals Inc (MIRM) were sold and 175,963 shares were bought by its insiders, resulting in a net sale of 217,481 shares.

Mirum Pharmaceuticals Inc (MIRM)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Marker Therapeutics Inc (MRKR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Marker Therapeutics Inc (MRKR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Marker Therapeutics Inc (MRKR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Ali Behbahani made no insider transaction in X4 Pharmaceuticals Inc (XFOR). Other recent insider transactions involving X4 Pharmaceuticals Inc (XFOR) include a net sale of 401,923 shares made by Paula Ragan , a net sale of 113,683 shares made by Mary Dibiase , and a net sale of 401,921 shares made by Adam S. Mostafa .

In summary, during the past 3 months, insiders sold 185,708 shares of X4 Pharmaceuticals Inc (XFOR) in total and bought 0 shares, with a net sale of 185,708 shares. During the past 18 months, 1,158,291 shares of X4 Pharmaceuticals Inc (XFOR) were sold and 25,000 shares were bought by its insiders, resulting in a net sale of 1,133,291 shares.

X4 Pharmaceuticals Inc (XFOR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Ali Behbahani made no insider transaction in Nevro Corp (NVRO). Other recent insider transactions involving Nevro Corp (NVRO) include a net purchase of 7,500 shares made by Shawn Mccormick ,

In summary, during the past 3 months, insiders sold 0 shares of Nevro Corp (NVRO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Nevro Corp (NVRO) were sold and 7,500 shares were bought by its insiders, resulting in a net purchase of 7,500 shares.

Nevro Corp (NVRO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Ali Behbahani made no insider transaction in Savara Inc (SVRA). Other recent insider transactions involving Savara Inc (SVRA) include a net purchase of 289,000 shares made by David A Ramsay , a net purchase of 10,000 shares made by Raymond Dennis Pratt , and a net purchase of 333,333 shares made by Rick Yang .

In summary, during the past 3 months, insiders sold 0 shares of Savara Inc (SVRA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 187,843 shares of Savara Inc (SVRA) were sold and 3,632,330 shares were bought by its insiders, resulting in a net purchase of 3,444,487 shares.

Savara Inc (SVRA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Ali Behbahani made no insider transaction in CVRx Inc (CVRX). Other recent insider transactions involving CVRx Inc (CVRX) include a net sale of 8,895 shares made by Paul Verrastro , and a net sale of 3,725 shares made by Johnson & Johnson .

In summary, during the past 3 months, insiders sold 6,270 shares of CVRx Inc (CVRX) in total and bought 0 shares, with a net sale of 6,270 shares. During the past 18 months, 12,620 shares of CVRx Inc (CVRX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 12,620 shares.

CVRx Inc (CVRX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Ali Behbahani made no insider transaction in Minerva Surgical Inc (UTRS). Other recent insider transactions involving Minerva Surgical Inc (UTRS) include a net purchase of 24,437,927 shares made by New Enterprise Associates 13 Lp ,

In summary, during the past 3 months, insiders sold 0 shares of Minerva Surgical Inc (UTRS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Minerva Surgical Inc (UTRS) were sold and 24,437,927 shares were bought by its insiders, resulting in a net purchase of 24,437,927 shares.

Minerva Surgical Inc (UTRS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Ali Behbahani made no insider transaction in NeueHealth Inc (NEUE). Other recent insider transactions involving NeueHealth Inc (NEUE) include a net sale of 451,635 shares made by Mikan George Lawrence Iii , a net sale of 51,710 shares made by Jeffrey J Scherman , and a net sale of 21,838 shares made by Jeff Michael Craig .

In summary, during the past 3 months, insiders sold 38,712 shares of NeueHealth Inc (NEUE) in total and bought 0 shares, with a net sale of 38,712 shares. During the past 18 months, 645,101 shares of NeueHealth Inc (NEUE) were sold and 1,185,000 shares were bought by its insiders, resulting in a net purchase of 539,899 shares.

NeueHealth Inc (NEUE)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Ali Behbahani made no insider transaction in Arcellx Inc (ACLX). Other recent insider transactions involving Arcellx Inc (ACLX) include a net sale of 265,284 shares made by Christopher Heery , a net sale of 124,266 shares made by Rami Elghandour , and a net sale of 1,987,663 shares made by Jill Carroll .

In summary, during the past 3 months, insiders sold 647,567 shares of Arcellx Inc (ACLX) in total and bought 0 shares, with a net sale of 647,567 shares. During the past 18 months, 3,441,046 shares of Arcellx Inc (ACLX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 3,441,046 shares.

Arcellx Inc (ACLX)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Monte Rosa Therapeutics Inc (GLUE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Monte Rosa Therapeutics Inc (GLUE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Monte Rosa Therapeutics Inc (GLUE)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Genocea Biosciences Inc (GGNNQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Genocea Biosciences Inc (GGNNQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Genocea Biosciences Inc (GGNNQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Ali Behbahani made no insider transaction in Korro Bio Inc (KRRO). Other recent insider transactions involving Korro Bio Inc (KRRO) include a net sale of 2,124 shares made by David L. Lucchino , a net purchase of 17,857 shares made by New Enterprise Associates 17, L.p. , and a net purchase of 17,857 shares made by Florence Anthony A. Jr. .

In summary, during the past 3 months, insiders sold 0 shares of Korro Bio Inc (KRRO) in total and bought 178,570 shares, with a net purchase of 178,570 shares. During the past 18 months, 2,124 shares of Korro Bio Inc (KRRO) were sold and 178,570 shares were bought by its insiders, resulting in a net purchase of 176,446 shares.

Korro Bio Inc (KRRO)'s detailed insider trading history can be found in Insider Trading Tracker table.